QUELMIA
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Jan 2019)
What this means for you
This application is over — abandoned 21 Jan 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86724536
- Mark type
- Stylized text
- Filed
- 13 Aug 2015
- Published for opposition
- 23 Feb 2016
- Abandoned
- 21 Jan 2019
- Attorney of record
- Matthew O. Brady
Goods and services
- Class 005 — Pharmaceuticals: Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to sensory organs; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Owner
- ALLERGAN FINANCE, LLC, PARSIPPANY, NJ, US
- Actavis, Inc, Parsippany, NJ, US
- Actavis, Inc, Parsippany, NJ, US
Prosecution history
- 22 Jan 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Jan 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 19 Jan 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jan 2019 — SOU EXTENSION 4 GRANTED
- 13 Apr 2018 — SOU EXTENSION 4 FILED
- 20 Oct 2018 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 18 Jan 2019 — REVIEW OF CORRESPONDENCE COMPLETE
- 20 Oct 2018 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 04 Sept 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Aug 2018 — ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
- 13 Apr 2018 — SOU TEAS EXTENSION RECEIVED
- 03 Jan 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 07 Oct 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Oct 2017 — SOU EXTENSION 3 GRANTED
- 05 Oct 2017 — SOU EXTENSION 3 FILED